Sabby Management’s 9 Meters Biopharma NMTR Stock Holding History

Sabby Management’s Portfolio NMTR Stock Details NMTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,672,627	Closed	-$20.1K	–	100
2023 Q3	$20.1K	Buy	1,672,627 +634,187	+61%	+$298K	0.01%	75
2023 Q2	$698K	Sell	1,038,440 -65,205	-6%	-$57.7K	0.57%	15
2023 Q1	$1.53M	Buy	+1,103,645	New	+$2.08M	1.34%	4
2021 Q2	–	Sell	-28,226	Closed	-$693K	–	195
2021 Q1	$661K	Buy	+28,226	New	+$867K	0.13%	95
2020 Q1	–	Sell	-47,079	Closed	-$525K	–	114
2019 Q4	$525K	Sell	47,079 -15,362	-25%	-$256K	0.15%	34
2019 Q3	$1.34M	Sell	62,441 -4,371	-7%	-$88.3K	0.72%	17
2019 Q2	$1.55M	Buy	+66,812	New	+$2M	1.95%	10

Sabby Management's NMTR Position: Q4 2023 in Review

Sabby Management sold out of 9 Meters Biopharma (NMTR) in Q4 2023, closing a stake of 1,672,627 shares — an estimated $20.1K sold.

Sabby Management first reported a position in NMTR in Q2 2019 and held it in 7 quarters. The position peaked at $1.55M in Q2 2019. 1 fund tracked by Wall St. Rank holds NMTR as of Q4 2023.

Sabby Management reported no remaining 9 Meters Biopharma position as of Q4 2023 after selling out during the quarter.
Sabby Management sold 1,672,627 9 Meters Biopharma shares in Q4 2023, an estimated $20.1K.
Sabby Management first reported a position in 9 Meters Biopharma in Q2 2019 and held it in 7 quarters.
Sabby Management's 9 Meters Biopharma position peaked at $1.55M in Q2 2019.
1 fund tracked by Wall St. Rank held 9 Meters Biopharma as of Q4 2023.

Based on Sabby Management's 13F filing for Q4 2023, filed 14 Feb 2024.